Videos

Dr. Don S. Dizon discusses how cancer centers can be more inclusive to the LGBTQ+ community, from the naming of the institutions to the types of magazines found in the waiting rooms.

In recent trial results, a dose reduction of Xpovio (selinexor) was associated with longer progression-free survival and duration of response while also reducing side effects in patients with multiple myeloma.

Clinical trial results show that adding Keytruda to chemotherapy prior to surgery for triple-negative breast cancer can improve outcomes and hopefully “increase the chances for patients to be cured,” according to an expert.

Watch the entire Metastatic Breast Cancer Heroes™ presentation here!

CURE®’s second episode of its cooking show, Heal at Home, is here! And this time, we are bringing cancer survivors, patients and their loved ones the nutrition with a dash of holiday cheer.

People who have successfully navigated difficult times in the past may be able to use those previous coping strategies to help them weather new stress related to a cancer diagnosis, treatment or survivorship, according to an expert from the George Washington University Cancer Center.

LeVar Burton, most noted for his roles in “Reading Rainbow” and “Star Trek”, stresses how important storytelling is — both in everyday life and in health care settings.

Several CURE® Calendar Contest winners describe their winning creations and discuss how they used art as a medium of coping with the struggles of cancer.

View the full CURE® Educated Patient® Webinar: Testing and Treatment for Non-Small Cell Lung Cancer on demand.

Some patients with kidney cancer do not need to rush into the operating room, explained Dr. Alexander Kutikov.

Several CURE® Calendar Contest winners explain the stories behind their winning artwork and how their artmaking helped them through the difficulties of cancer.

The panel provides closing thoughts on patient advocacy and advocacy activities.

Julie Larson, LCSW, provides insight into reasons for joining clinical trials, finding trials from peers, and trials for purposes other than cancer treatment.

Patient Jocelyn Mueller and oncologist Julia Fisher, M.D., describe some of the adjustments that had to be made to Jocelyn’s treatment for HER2-positive breast cancer due to the COVID-19 pandemic.

The panel discusses resources available for locating relevant clinical trials for patients with metastatic breast cancer.

Shirley Mertz, MA, JD, provides an overview of clinical trials and how they are conducted.

View the full CURE® Educated Patient® Webinar: Meet the 2021 Lung Cancer Heroes® on demand.

View the full CURE Educated Patient Breast Cancer Summit Outside of Therapy Session on demand.

View the full CURE Educated Patient Breast Cancer Summit Novel Therapies Session on demand.

View the full CURE Educated Patient Breast Cancer Summit Multi-Disciplinary Approaches to Early-Stage Breast Cancer Session on demand.

Julie Fisher, M.D., has a conversation with patient Jocelyn Mueller about the importance of good support networks when living with HER2-positive breast cancer.

Jocelyn Mueller details how chemotherapy treatments have affected her daily life and her decision to receive treatment through a port.

Sheila McGlown provides insight into the underrepresentation of women of color in clinical trials for breast cancer and discusses reasons for these disparities.

The panel elaborates on the racial disparities in the care of breast cancer and the need for systemic change to address these disparities.

View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part III – Survivorship and Mental Health

Take-home messages from a discussion on the use of biomarker testing, and newer, novel-based strategies to treat patients with non-small cell lung cancer.

Preferences for rechallenging patients with non-small cell lung cancer with immunotherapy based on previous experiences in terms of treatment-related side effects.

Julie Fisher, MD, explains how she assesses HER2-positive breast cancer patients for treatment response, what side-effects can occur and how they can be managed.

Strategies that can help various health care professionals best mitigate or manage side effects associated with newer treatments in non-small cell lung cancer, such as immunotherapy.

Jocelyn Mueller describes the preoperative treatments she has received for HER2-positive breast cancer, and the questions she had for her medical care team.